LOW DOSE COMBINATION CDA SUBSTRATE DRUG/CEDAZURIDINE WITH EXTENDED ADMINISTRATION

• 收藏
• 分享

专利权人:

Ltd.;Otsuka Pharmaceutical Co.

发明人:

Harold Keer,Mohammad Azab,Aram Oganesian

申请号：

US16574924

公开号：

US20200085848A1

申请日:

2019.09.18

申请国别(地区):

US

年份:

2020

代理人:

摘要：

This invention relates to methods and compositions for administering an effective amount of a CDA substrate drug and an effective amount of cedazuridine. In particular, the invention relates to methods for treating cancer, inhibiting degradation of a CDA substrate drug, and reducing DNA methylation in a subject in need thereof comprising administering an effective amount of a CDA substrate drug and an effective amount of cedazuridine.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/